Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study. (Q51286470)
Jump to navigation
Jump to search
scientific article published in December 2016
Language | Label | Description | Also known as |
---|---|---|---|
English | Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study. |
scientific article published in December 2016 |
Statements
Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study. (English)
1 reference
1 reference
William C Gruber
1 reference
Kathrin U Jansen
1 reference
C Buddy Creech
1 reference
Robert W Frenck
1 reference
David J Seiden
1 reference
Martin K Kankam
1 reference
James Baber
1 reference
Edward Zito
1 reference
Robin Hubler
1 reference
Joseph Eiden
1 reference
Joseph M Severs
1 reference
Shite Sebastian
1 reference
Jasdeep Nanra
1 reference
Annaliesa S Anderson
1 reference
Douglas Girgenti
1 reference
1 December 2016
1 reference
35
1 reference
2
1 reference
375-384
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference